International Clinical Trial: Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07831746) titled 'Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: UMC Utrecht

Condition: Perinatal Arterial Ischemic Stroke Perinatal Asphyxia Hypoxic-Ischemic Brain Injury PAIS HIE - Hypoxic - Ischemic Encephalopathy

Intervention: Drug: MSC, marrow

Recruitment Status: Not recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: April 1, 2027

Ta...